Phage therapy: Past history and future prospects

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 5, 1999, Pages 267-274

  Carlton, Richard M ^a  

^a Exponential Biotherapies Inc   (United States)

Author keywords

Bacterial infections; Bacterial viruses; Bacteriophage; Multidrug resistance; Phage

Indexed keywords

ANTIINFECTIVE AGENT; VIRUS ANTIBODY;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; BIOSYNTHESIS; CHICKEN; CLINICAL TRIAL; EASTERN EUROPE; ENTEROBACTER INFECTION; FORECASTING; GENETIC ENGINEERING; HUMAN; IMMUNOLOGY; LYSOGENIZATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MOUSE; MULTIDRUG RESISTANCE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RABBIT; RAT; REVIEW; THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, VIRAL; BACTEREMIA; BACTERIAL INFECTIONS; BACTERIOPHAGE LAMBDA; BACTERIOPHAGES; CHICKENS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI INFECTIONS; EUROPE, EASTERN; FORECASTING; GENETIC ENGINEERING; HUMANS; LYSOGENY; METABOLIC CLEARANCE RATE; MICE; PHARMACOKINETICS; RABBITS; RATS; RESEARCH DESIGN; THERAPEUTICS; TREATMENT OUTCOME;

EID: 0033256572     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ACKERMANN H. -W. and DUBOW M. (1987): Viruses of prokaryotes I: General properties of bacteriophages (chapter 7). Practical applications of bacteriophages. CRC Press, Boca Raton, Florida.
2. ALISKY J. et al. (1998): Bacteriophages show promise as anti-microbial agents. J. Infect., 36, 5-15.
3. BARROW P. A. and SOOTHILL J. S. (1997): Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of the potential. Trends Microbiol., 5, 268-271.
4. BERCHIERI A. et al. (1991): The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res. Microbiol., 142, 541-549.
5. D'HÉRELLE F. (1917): Sur un microbe invisible antagoniste des bac. dysentériques. Crit. Rev. Acad. Sci. Paris, 165, 373.
6. D'HÉRELLE F. (1922): The bacteriophage: its role in immunity. Williams and Wilkens Co./Waverly Press, Baltimore, USA.
7. GEIER M., FRIGG M. E. and MERRIL C. (1973): Fate of bacteriophage lambda in non-immune germ-free mice. Nature, 246, 221-222.
8. LEDERBERG J. (1996): Commentary. Proc. Natl. Acad. Sci. USA, 93, 3167-3168.
9. LEVIN B. and BULL J. J. (1996): Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Naturalist, 147, 881-898.
10. LEVY S. (1992): The antibiotic paradox. Plenum Press, New York.
11. MERRIL C. et al. (1996): Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA, 93, 3188-2192.
12. MURRAY B. (1998): Diversity among multidrug-resistant Enterococci. Emerging Infect. Dis., 4, 37-47.
13. SHRAYER D. (1996): Felix d'Hérelle in Russia. Bull. Inst. Pasteur, 94, 91-96.
14. SMITH H. W. and HUGGINS R. B. (1982): Successful treatment of experimental E. coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol., 128, 307-318.
15. SMITH H. W. and HUGGINS R. B. (1983): Effectiveness of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol., 129, 2659-2675.
16. SMITH H. W. und HUGGINS R. B. (1987): The control of experimental E. coli diarrhea in calves by means of bacteriophage. J. Gen. Microbiol., 133, 1111-1126.
17. SMITH T. et al. (1999): Emergence of vancomycin resistance in Staphylococcus, aureus. N. Engl. J. Med., 340, 493-501.
18. SOOTHILL J. S. (1992): Treatment of experimental infections of mice with bacteriophages. Med. Microbiol., 37, 258-261.
19. SUMMERS W. C. (1998): D'Hérelle. Yale University Press (in press).
20. ŚLOPEK S. and KUCHAREWICZ-KRUKOWSKA A. (1987): Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp., 35, 553-561.
21. ŚLOPEK S., KICHAREWICZ-KRUKOWSKA A., WEBER-DABROWSKA B. and DABROWSKI M. (1985): Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp., 33, 219-240.
22. ŚLOPEK S., KUCHAREWICZ-KRUKOWSKA A., WEBER-DABROWSKA B. and DABROWSKI M. (1985): Results of bacteriophage treatment of suppurative bacterial infections VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp., 33, 261-273.
23. ŚLOPEK S., WEBER-DABROWSKA B., DABROWSKI M. and KUCHAREWICZ-KRUKOWSKA A. (1987): Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch. Immunol. Ther. Exp., 35, 569-583.
24. VAN HELVOORT T. (1992): Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon. Med. Hist., 36, 243-270.
25. WALDVOGEL F. (1999): New resistance in Staphylococcus aureus. N. Engl. J. Med., 340, 556-557.
26. WEBER-DABROWSKA B., DABROWSKI M. and ŚLOPEK S. (1987): Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp., 35, 563-568.